News & Events about Bio Rad Laboratories Inc.
StockNews.com lowered shares of Bio-Rad Laboratories (NYSE:BIO Get Rating) from a buy rating to a hold rating in a research note released on Wednesday. Several other research analysts have also recently issued reports on BIO. Credit Suisse Group dropped their price target on Bio-Rad Laboratories ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at...
Business Wire
3 months ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the companys management will participate in a Fireside Chat event during the Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, 2022...
Business Wire
3 months ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the third quarter of 2022 on Thursday, October 27, 2022, following the close of the market. Management will discuss these results in a...